The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans

• Published in: American journal of physiology: endocrinology and metabolism Vol. 314; no. 3; pp. E266 - E273
• Main Authors: Peter, Andreas, Kovarova, Marketa, Staiger, Harald, Machann, Jürgen, Schick, Fritz, Königsrainer, Alfred, Königsrainer, Ingmar, Schleicher, Erwin, Fritsche, Andreas, Häring, Hans-Ulrich, Stefan, Norbert
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 01.03.2018
• Subjects: Aged; alpha-2-HS-Glycoprotein - analysis; alpha-2-HS-Glycoprotein - genetics; alpha-2-HS-Glycoprotein - metabolism; Cohort Studies; Fatty liver; Fatty Liver - blood; Fatty Liver - genetics; Fatty Liver - metabolism; Fatty Liver - pathology; Female; Fetuin-B - analysis; Fetuin-B - genetics; Fetuin-B - metabolism; Gene expression; Genotype & phenotype; Glucose; Glucose tolerance; Glucose Tolerance Test; Health risks; Homeostasis; Humans; Impact analysis; Insulin; Insulin resistance; Insulin Resistance - physiology; Liver; Liver - metabolism; Liver - pathology; Liver diseases; Male; Middle Aged; Non-alcoholic Fatty Liver Disease - blood; Non-alcoholic Fatty Liver Disease - genetics; Non-alcoholic Fatty Liver Disease - pathology; Phenotyping; Proteins; RNA, Messenger - analysis; RNA, Messenger - metabolism; Rodents; Sensitivity; Signaling; Steatosis; Up-Regulation - genetics; fetuin-A; glucose homeostasis; fatty liver; hepatokines; fetuin-B; insulin resistance
• ISSN: 0193-1849; 1522-1555
• DOI: 10.1152/ajpendo.00262.2017

The liver is a central regulator of whole body glucose, and lipid homeostasis and hepatokines, like fetuin-A, have been identified as markers and mediators of fatty liver-induced cardiometabolic risk. The closely related protein fetuin-B was shown to be upregulated in the fatty liver and to impact on glucose homeostasis in mice. In the present study we aimed to test the relevance of these findings in humans. In 55 subjects, hepatic mRNA expression of both hepatokines, fetuin-A and fetuin-B, associated positively with liver triglyceride content, whereas only fetuin-A expression associated with the homeostatic model assessment of insulin resistance. In 220 subjects who underwent precise metabolic phenotyping, circulating fetuin-A, but not fetuin-B, associated positively with liver fat content, and negatively with insulin sensitivity, measured during the oral glucose tolerance test (OGTT) and during the euglycemic, hyperinsulinemic clamp. Both circulating fetuin-A and fetuin-B correlated positively with the glucose area under the curve during the OGTT, but after additional adjustment for insulin sensitivity this relationship remained significant only for fetuin-B. In conclusion, despite the fact that the two hepatokines, fetuin-A and fetuin-B, are upregulated in the state of hepatic steatosis in humans, it appears that they differently impact on glucose homeostasis. Our data are in agreement with observations that fetuin-A can alter insulin signaling and that fetuin-B may regulate glucose homeostasis via so far unknown effects, possibly on glucose effectiveness.